| Old Articles: <Older 54511-54520 Newer> |
|---|
 |
The Motley Fool
December 28, 2011
Brian Orelli |
Biotech Post-Holiday Regifting A pair of biotechs were on the receiving end of some holiday jeers today as their pharma partners appear to be uninterested in the drugs they were given.   |
The Motley Fool
December 28, 2011
Brian Stoffel |
Empire District Picked Itself Up off the Canvas in 2011 A tornado wreaked havoc on a utility provider operating in Kansas, Oklahoma and -- most notably this year -- Missouri. |
The Motley Fool
December 28, 2011
John Grgurich |
Netflix Last in Customer Satisfaction: What Investors Need to Know A ForeSee survey reveals the worst performers. |
The Motley Fool
December 28, 2011
Isac Simon |
2011 Bakken Review: Part 1 Has this shale play lived up to its hype? |
The Motley Fool
December 28, 2011
Chris Hill |
1 Big Secret to Intel's Success In his latest book, Great By Choice, Jim Collins discusses how the disciplined approach the leaders at Intel have taken has helped pave the way for the chipmaker's success. |
The Motley Fool
December 28, 2011
Anders Bylund |
Can TriQuint Turn Things Around in 2012? This year has not been kind to the chip builder. Will the next one be any better? |
The Motley Fool
December 28, 2011
Rick Aristotle Munarriz |
4 Things That SodaStream Must Do In 2012 The soda maker needs more fizz in the year ahead. |
The Motley Fool
December 28, 2011
Sean Williams |
My Top 10 CEOs of 2011: Part 2 Santa Claus delivers year-round for these shareholders, thanks to these CEOs. |
The Motley Fool
December 28, 2011
Sean Williams |
My Top 10 CEOs of 2011 Santa Claus delivers year-round for these shareholders, thanks to these CEOs. |
The Motley Fool
December 28, 2011
Dan Radovsky |
Brocade's Roller-Coaster Year Can Brocade recover from its midyear vertigo? |
| <Older 54511-54520 Newer> Return to current articles. |
